Given the critical importance of cellular life-or-death decisions to anti-cancer strategies, therapeutic genome editing approaches, and our expanding view of aberrant p53 activity in developmental disorders, a large number of studies have addressed the question of how the p53 signaling pathway makes this ultimate decision about a cell’s life or death [5]. Here, TP53 is linked to cancer.